Morgan Stanley Overweight On RadNet

Morgan Keegan is out with a research report on RadNet, Inc. RDNT and it has an Outperform rating and a $5.15 price target on shares. In a note to clients, Morgan Keegan writes, "Our EPS estimate of $0.05 is $0.01 below the First Call consensus and up from $0.02 in the prior year period. However, we believe a better measure of RadNet profitability is adjusted EBITDA. We have modeled $30 million versus $27.4 million in the prior year period. Since adjusted EBITDA is a non-GAAP measure there is no consensus estimate." Shares of RDNT gained 17 cents on Friday to close at $3.75.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!